234 related articles for article (PubMed ID: 10461358)
1. Pathogenesis of ECL cell tumors in humans.
Bordi C; D'Adda T; Azzoni C; Ferraro G
Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
[TBL] [Abstract][Full Text] [Related]
2. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects of ECL-cell abnormalities.
Hirschowitz BI
Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
5. Relationship of ECL cells and gastric neoplasia.
Waldum HL; Brenna E; Sandvik AK
Yale J Biol Med; 1998; 71(3-4):325-35. PubMed ID: 10461363
[TBL] [Abstract][Full Text] [Related]
6. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
7. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
8. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
[TBL] [Abstract][Full Text] [Related]
10. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
11. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.
Varro A; Kenny S; Hemers E; McCaig C; Przemeck S; Wang TC; Bodger K; Pritchard DM
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1133-40. PubMed ID: 17218472
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine proliferation in the gastric mucosa: biological behaviour and management.
Bordi C; D'Adda T; Azzoni C; Aprile MR; Pilato FP; Ferraro G
Verh Dtsch Ges Pathol; 1997; 81():103-10. PubMed ID: 9474860
[TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoids.
Bordi C
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
[TBL] [Abstract][Full Text] [Related]
14. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia].
Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z
Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of ECL cell tumors.
Cadiot G; Cattan D; Mignon M
Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
[TBL] [Abstract][Full Text] [Related]
17. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Solcia E; Rindi G; Silini E; Villani L
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
[TBL] [Abstract][Full Text] [Related]
18. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
[TBL] [Abstract][Full Text] [Related]
19. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
[TBL] [Abstract][Full Text] [Related]
20. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
